Related Experiment Video

Updated: Jul 15, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Diagnosing fungal infections in neutropenic patients

Alison Gardner1

  • 1University of Texas M.D. Anderson Cancer Center, Houston, USA. agardner@mdanderson.org

Clinical Journal of Oncology Nursing
|April 20, 2007
PubMed

Insights

Diagnosing fungal infections in neutropenic patients is difficult due to a lack of effective tools. Early detection of disseminated candidiasis remains a challenge, impacting patient outcomes.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Fungal infections pose a significant threat to neutropenic patients.
  • Current diagnostic methods for fungal infections are inadequate, hindering timely treatment.
  • Low specificity of radiologic tests and low sensitivity of blood cultures complicate early diagnosis.

Purpose of the Study:

  • To highlight the challenges in diagnosing fungal infections in neutropenic patients.
  • To emphasize the need for improved diagnostic tools for early detection.
  • To discuss the limitations of existing diagnostic approaches.

Main Methods:

  • Review of current diagnostic challenges in neutropenic patients.
  • Analysis of limitations in blood culture sensitivity and radiologic test specificity.
  • Discussion of efforts to develop serologic tests for fungal antigen detection.

Main Results:

  • Fungal infections are a major cause of morbidity and mortality in neutropenic individuals.
  • Diagnostic confirmation of fungal infections is often delayed due to tool limitations.
  • Existing diagnostic methods, including blood cultures and imaging, have significant shortcomings.

Conclusions:

  • Improved diagnostic tools are crucial for effective management of fungal infections in neutropenic patients.
  • Development of serologic tests for fungal antigens represents a promising area for research.
  • Timely and accurate diagnosis is essential to improve outcomes for neutropenic patients with fungal infections.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...